TABLE 1.

Adverse Reactions in Placebo-Controlled Studies of 6-Week Treatment Duration and Reported in ≥ 2% and > Placebo³⁴

	Placebo (n = 231, %)	Pimavanserin 34 mg (n = 202, %)
Nausea	4	7
Constipation	3	4
Peripheral edema	2	7
Gait disturbance	< 1	2
Hallucinationsa	3	5
Confusional state	3	6

^aHallucinations include visual, auditory, tactile, and somatic hallucinations.